Purdue Pharma Stock Analysis: An Overview
Key Statistics and Fundamentals
Purdue Pharma Inc (PAC 0578928DUS) is a pharmaceutical company specializing in pain medication. The company's stock price has been volatile in recent years, reflecting the ongoing legal challenges it faces.
Stock Price and Chart
As of today's market close, the stock price of Purdue Pharma is $4.52 per share. Over the past year, the stock has ranged between $2.50 and $5.50 per share.
Recent News and Developments
Purdue Pharma has been involved in several lawsuits and investigations related to its marketing and sales practices of OxyContin. The company has reached a $83 billion settlement with states and municipalities over its role in the opioid crisis.
As part of the settlement, Purdue Pharma will plead guilty to criminal charges and be dissolved. The Sackler family, the company's former owners, will pay $4.5 billion to settle their own lawsuits.
Next Steps and Potential Hurdles
The settlement and dissolution of Purdue Pharma represent a significant step towards resolving the opioid crisis. However, there are still several potential hurdles that could delay or derail the process.
These hurdles include:
*Conclusion
The stock analysis of Purdue Pharma Inc provides insights into the company's financial performance and legal challenges. As the company moves closer to exiting bankruptcy, it remains to be seen how these factors will impact its long-term viability.
Comments